GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » Equity-to-Asset

Cybin (CYBN) Equity-to-Asset : 0.93 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Cybin Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cybin's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $90.36 Mil. Cybin's Total Assets for the quarter that ended in Dec. 2023 was $96.69 Mil.

The historical rank and industry rank for Cybin's Equity-to-Asset or its related term are showing as below:

CYBN' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.81   Med: 0.92   Max: 0.94
Current: 0.93

During the past 4 years, the highest Equity to Asset Ratio of Cybin was 0.94. The lowest was 0.81. And the median was 0.92.

CYBN's Equity-to-Asset is ranked better than
91.53% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs CYBN: 0.93

Cybin Equity-to-Asset Historical Data

The historical data trend for Cybin's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Equity-to-Asset Chart

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
0.85 0.94 0.91 0.90

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.93 0.90 0.87 0.84 0.93

Competitive Comparison of Cybin's Equity-to-Asset

For the Biotechnology subindustry, Cybin's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cybin's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cybin's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cybin's Equity-to-Asset falls into.



Cybin Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cybin's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=35.251/39.39
=

Cybin's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=90.356/96.694
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cybin  (AMEX:CYBN) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cybin Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cybin's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cybin (CYBN) Business Description

Traded in Other Exchanges
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.